Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Feb 15, 2022; 13(2): 126-128
Published online Feb 15, 2022. doi: 10.4239/wjd.v13.i2.126
Published online Feb 15, 2022. doi: 10.4239/wjd.v13.i2.126
Inflammatory bowel disease and diabetes: Is there a link between them?
Miao-Miao Sang, Zi-Lin Sun, Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing 210009, Jiangsu Province, China
Tong-Zhi Wu, Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, SA 5000, Australia
Author contributions: Sang MM wrote the letter; Sun ZL and Wu TZ revised the letter.
Conflict-of-interest statement: The authors declare that they have no conflict-of-interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tong-Zhi Wu, Doctor, MD, PhD, Associate Professor, Senior Research Fellow, Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Level 6, Adelaide Health and Medical Science Building, North Terrace, Adelaide, SA 5000, Australia. tongzhi.wu@adelaide.edu.au
Received: September 11, 2021
Peer-review started: September 11, 2021
First decision: December 4, 2021
Revised: December 9, 2021
Accepted: January 14, 2022
Article in press: January 14, 2022
Published online: February 15, 2022
Peer-review started: September 11, 2021
First decision: December 4, 2021
Revised: December 9, 2021
Accepted: January 14, 2022
Article in press: January 14, 2022
Published online: February 15, 2022
Abstract
Patients with inflammatory bowel disease (IBD) are reported to have an increased risk of diabetes. IBD therapies may also modulate blood glucose substantially. These observations are indicative of mechanistic connection(s) between IBD and diabetes.
Core Tip: Inflammatory bowel disease is associated with an increased risk of diabetes. Mechanistic insights into their common pathogenesis may render novel therapeutic targets for these major chronic disorders.